Following our presence at Arab Health 2023 we had the opportunity to speak with BioVoice, the top Indian bioscience news magazine.
In the interview, our CEO Daniela Marino shared the progress that CUTISS has been making in bioengineering the personalized skin graft denovoSkin, the commercial plans around skin pigmentation, and the exciting innovations in regenerative medicine. You can read the interview in the pdf below, or directly online here.
